Literature DB >> 9372975

The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.

A Davenport1.   

Abstract

Continuous renal replacement therapy (CRRT) has been advocated as the treatment of choice in critically ill patients with renal failure. However, to be as effective as intermittent hemodialysis in terms of small molecule clearance, the extracorporeal CRRT circuit must operate continuously, 24 hours a day, day after day. This review examines both patient and extracorporeal factors that may lead to premature clotting within the CRRT circuit, and approaches that may reduce extracorporeal clotting.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9372975     DOI： 10.1016/s0272-6386(97)90538-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


  8 in total

1.  Effects of increased surface coverage of polyvinylpyrrolidone over a polysulfone hemofilter membrane on permeability and cell adhesion during continuous hemofiltration.

Authors:  Kenichi Kokubo; Yoshitaka Kurihara; Hiroshi Tsukao; Naoko Maruyama; Kozue Kobayashi; Toshihiro Shinbo; Minoru Hirose; Hirosuke Kobayashi
Journal:  J Artif Organs       Date:  2015-04-03       Impact factor: 1.731

Review 2.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

3.  Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit.

Authors:  Sean M Bagshaw; Andrew Davenport
Journal:  Intensive Care Med       Date:  2008-10-08       Impact factor: 17.440

4.  Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system.

Authors:  Esther B Bachli; Jörg Bösiger; Markus Béchir; John F Stover; Reto Stocker; Marco Maggiorini; Eberhard L Renner; Beat Müllhaupt; Reto A Schuepbach
Journal:  Crit Care Res Pract       Date:  2011-03-06

Review 5.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

6.  The effects of continuous venovenous hemofiltration on coagulation activation.

Authors:  Catherine S C Bouman; Anne-Cornélie J M de Pont; Joost C M Meijers; Kamran Bakhtiari; Dorina Roem; Sacha Zeerleder; Gertjan Wolbink; Johanna C Korevaar; Marcel Levi; Evert de Jonge
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Impact of acute kidney injury on coagulation in adult minimal change nephropathy.

Authors:  Meng-Jie Huang; Ri-Bao Wei; Ting-Yu Su; Yang Wang; Qing-Ping Li; Xi Yang; Xiao-Meng Lv; Xiang-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

8.  Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients.

Authors:  Wei Zhang; Ming Bai; Ling Zhang; Yan Yu; Yangping Li; Lijuan Zhao; Yuan Yue; Yajuan Li; Min Zhang; Ping Fu; Shiren Sun; Xiangmei Chen
Journal:  Blood Purif       Date:  2021-10-21       Impact factor: 3.348
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.